You are here

Amarin

Amarin Dangles A Carrot On A Mile Long String

Seeking Alpha

Tue, 12/3/13 - 11:30 am

Amarin in Deep Hole so Top Execs Get Cash Bonus Offer

TheStreet.com

Tue, 12/3/13 - 11:02 am

Any Hopes Left For Amarin Bulls?

Seeking Alpha

Sun, 12/1/13 - 10:38 am

FDA to Amarin: No Appeal for You

Motley Fool

Sat, 11/23/13 - 12:47 pm

Amarin faces another setback on expanded use of its lead drug

Yahoo/Reuters

Fri, 11/22/13 - 10:24 am

Why The FDA Got It Wrong And Why It Will Approve Vascepa For ANCHOR SNDA Submission

Seeking Alpha

Tue, 11/19/13 - 07:42 am

Amarin, Sarepta And Vanda: Teachable Moments In Biotech

Seeking Alpha

Sun, 11/17/13 - 12:13 pm

Amarin: How Cost Cutting Affects Cash Burn And Profitability

Seeking Alpha

Fri, 11/15/13 - 04:54 pm

5 FDA-Approved Drugs That Disappointed Investors in 2013

Motley Fool

Wed, 11/13/13 - 10:33 pm

Arena Pharmaceuticals

Ariad Pharmaceuticals

Amarin Appeals FDA Rescission Of Special Protocol Agreement

Pharmalot

Fri, 11/8/13 - 11:57 am

Amarin's Q3 Call Points To Dark Days Ahead

Seeking Alpha

Fri, 11/8/13 - 08:39 am

2 Drug Promotions Going in Opposite Directions

Motley Fool

Fri, 11/1/13 - 08:26 am

Arena Pharmaceuticals

FDA Throws More Cold Water On Amarin's Hopes For Vascepa

Forbes

Wed, 10/30/13 - 10:03 am

What Might Amarin Be Worth to GlaxoSmithKline or Others?

Motley Fool

Mon, 10/28/13 - 09:29 am

Amarin Could Still Turn Profitable

Seeking Alpha

Thu, 10/24/13 - 10:03 am

Amarin slashes staff by half after FDA panel rejection

Fierce Pharma

Wed, 10/23/13 - 06:33 pm

Is Amarin Going Belly-Up?

Seeking Alpha

Mon, 10/21/13 - 04:16 pm

Is Amarin's FDA Panel Important for Other Cardiovascular Drugmakers?

Motley Fool

Thu, 10/17/13 - 06:12 pm

Amarin's Downfall? Other People's Data

Seeking Alpha

Thu, 10/17/13 - 03:47 pm

Pages